Overcoming MET-Dependent Resistance to Selective RET Inhibition in Patients with RET Fusion–Positive Lung Cancer by Combining Selpercatinib with Crizotinib
暂无分享，去创建一个
B. Taylor | M. Ladanyi | A. Drilon | P. Jänne | R. Somwar | Melissa L. Johnson | J. Hechtman | M. Davare | B. Nair | L. Sholl | G. Oxnard | K. Ebata | Bob T. Li | S. Rothenberg | E. Ivanova | E. Rosen | Arrien A Bertram | M. Vojnic | Jieun Son | S. Clifford | J. Kherani | E. Gladstone | D. Henry | Elaine M. Kelley | Mika Lin | M. S. Milan | E. Olek | Jenna E Scanlon | Arrien A. Bertram | M. Johnson | Dahlia N. Henry | Ezra Rosen